Structure‐activity relationship of a pyrimidine receptor in the rat isolated superior cervical ganglion
1 The effects of pyrimidines and purines on the d.c. potential of the rat isolated superior cervical ganglion (SCG) have been examined by a grease‐gap technique to determine the structure‐activity requirements of the receptor activated by pyrimidines, i.e. a pyrimidinoceptor. 2 5‐Ammoimidazole‐4‐car...
Gespeichert in:
Veröffentlicht in: | British journal of pharmacology 1995-11, Vol.116 (6), p.2764-2770 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2770 |
---|---|
container_issue | 6 |
container_start_page | 2764 |
container_title | British journal of pharmacology |
container_volume | 116 |
creator | Connolly, G.P. Harrison, P. J. |
description | 1
The effects of pyrimidines and purines on the d.c. potential of the rat isolated superior cervical ganglion (SCG) have been examined by a grease‐gap technique to determine the structure‐activity requirements of the receptor activated by pyrimidines, i.e. a pyrimidinoceptor.
2
5‐Ammoimidazole‐4‐carboxamide‐1‐β‐D‐ribofuranosyl (ZTP), the pyrimidines, cytidine 5′‐triphosphate (CTP), uridine 5′‐triphosphate (UTP) and thymidine 5′‐triphosphate (TIT) and the purines, adenosine 5′‐triphosphate (ATP; in the presence of an A1‐purinoceptor antagonist 8‐cyclopentyl‐1,3‐dipropylxanthine (DPCPX) (1 μ)), adenosine 5′‐O‐(3‐thiotriphosphate) (ATPγS), guanosine 5′‐triphosphate (GTP), inosine 5′‐triphosphate (ITP) depolarized ganglia in a concentration‐dependent manner. The relative order of ZTP and purine 5′‐triphosphates in depolarizing ganglia was ZTP≥ATPγS > > ATP ≥ ITP=GTP, and for the pyrimidine 5′‐triphosphates UTP > TTP ≥ CTP. Depolarizations evoked by ATPγS were followed by concentration‐dependent hyperpolarizations at 100 and 1000 μm.
3
At concentrations of between 0.1 μm and 1 mm, uridine 5′‐diphosphate (UDP), uridine 5′‐diphospho‐glucose (UDPG) and uridine 5′‐diphosphoglucuronic acid (UDPGA) evoked significant and concentration‐dependent depolarizations, whereas uridine 5′‐monophosphate (UMP), uridine and uracil were inactive or produced small (< 45 μV) depolarizations. The relative order of potency of uridine analogues in depolarizing ganglia was UDP ≥ UTP > UDPG > UDPGA > > uracil≥ UMP=pseudour‐idine≥ uridine. At 3 and 10 mm, uridine produced concentration‐dependent hyperpolarizations. Nikkomycin Z, a nucleoside resembling UTP (viz. the triphosphate chain at the 5′‐position on the ribose moiety being replaced by a peptide), was inactive between 1 μm and 1 mm. Generally, a concentration of 10 mm was required before thymidine, 6‐azathymine, 6‐azauracil or 6‐azauridine depolarized ganglia.
4
Suramin (300 μm), a P2‐purinoceptor antagonist, significantly depressed depolarizations evoked by α,β‐methylene‐ATP (α,β‐MeATP; 100 μm), ATPγS (100 μm), CTP (1 μm), GTP (1 μm), ZTP (30 μm) and ATP (300 μm) in the presence of DPCPX (1 μm). Suramin reversed a small depolarization evoked by UMP (1 μm) into a small hyperpolarization. In contrast depolarizations evoked by UDP, UTP, UDPG (all at 100 μm) and TTP (300 μm) were unaltered or enhanced by suramin.
5
It is concluded that the rat SCG contains distinct nucleotide receptors including a P2‐purinoceptor (activated by α,β‐MeA |
doi_str_mv | 10.1111/j.1476-5381.1995.tb17239.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1909137</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77827649</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5389-135bcdb682a510c5955db1c587c55f1681614907e369b8dac258eb7485d5f50a3</originalsourceid><addsrcrecordid>eNqVkdGK1DAUhoMo67j6CEIQ8a41p53TJF6IuqgrLCio1yFN05kMnbYm6bhzt4-wz-iTmNkpg16JuWnC95-fv-cn5BmwHNJ5uclhyasMSwE5SIl5rIEXpcyv75HFCd0nC8YYzwCEeEgehbBhLEGOZ-RMoATGigVxX6OfTJy8_XVzq010Oxf31NtORzf0Ye1GOrRU03Hv3dY1rrcJGjvGwVPX07hObx2pC0OasA0N02i9S9BYv3NGd3Sl-1WXvB6TB63ugn0yf8_J9w_vv11cZlefP366eHuVmRRaZlBibZq6EoVGYAYlYlODQcENYguVgAqWknFbVrIWjTYFClvzpcAGW2S6PCevj77jVG9tY2wfve7UmPJrv1eDdupv0ru1Wg07BZJJKHkyeDEb-OHHZENUWxeM7Trd22EKinNR8Gop_ykEztK6JSbhq6PQ-CEEb9tTGmDq0KjaqENt6lCbOjSq5kbVdRp--uf_nEbnChN_PnMd0r5br3vjwklWpF3hXdg3R9lP19n9fwRQ775c3l3L32PmwgM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17047795</pqid></control><display><type>article</type><title>Structure‐activity relationship of a pyrimidine receptor in the rat isolated superior cervical ganglion</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Connolly, G.P. ; Harrison, P. J.</creator><creatorcontrib>Connolly, G.P. ; Harrison, P. J.</creatorcontrib><description>1
The effects of pyrimidines and purines on the d.c. potential of the rat isolated superior cervical ganglion (SCG) have been examined by a grease‐gap technique to determine the structure‐activity requirements of the receptor activated by pyrimidines, i.e. a pyrimidinoceptor.
2
5‐Ammoimidazole‐4‐carboxamide‐1‐β‐D‐ribofuranosyl (ZTP), the pyrimidines, cytidine 5′‐triphosphate (CTP), uridine 5′‐triphosphate (UTP) and thymidine 5′‐triphosphate (TIT) and the purines, adenosine 5′‐triphosphate (ATP; in the presence of an A1‐purinoceptor antagonist 8‐cyclopentyl‐1,3‐dipropylxanthine (DPCPX) (1 μ)), adenosine 5′‐O‐(3‐thiotriphosphate) (ATPγS), guanosine 5′‐triphosphate (GTP), inosine 5′‐triphosphate (ITP) depolarized ganglia in a concentration‐dependent manner. The relative order of ZTP and purine 5′‐triphosphates in depolarizing ganglia was ZTP≥ATPγS > > ATP ≥ ITP=GTP, and for the pyrimidine 5′‐triphosphates UTP > TTP ≥ CTP. Depolarizations evoked by ATPγS were followed by concentration‐dependent hyperpolarizations at 100 and 1000 μm.
3
At concentrations of between 0.1 μm and 1 mm, uridine 5′‐diphosphate (UDP), uridine 5′‐diphospho‐glucose (UDPG) and uridine 5′‐diphosphoglucuronic acid (UDPGA) evoked significant and concentration‐dependent depolarizations, whereas uridine 5′‐monophosphate (UMP), uridine and uracil were inactive or produced small (< 45 μV) depolarizations. The relative order of potency of uridine analogues in depolarizing ganglia was UDP ≥ UTP > UDPG > UDPGA > > uracil≥ UMP=pseudour‐idine≥ uridine. At 3 and 10 mm, uridine produced concentration‐dependent hyperpolarizations. Nikkomycin Z, a nucleoside resembling UTP (viz. the triphosphate chain at the 5′‐position on the ribose moiety being replaced by a peptide), was inactive between 1 μm and 1 mm. Generally, a concentration of 10 mm was required before thymidine, 6‐azathymine, 6‐azauracil or 6‐azauridine depolarized ganglia.
4
Suramin (300 μm), a P2‐purinoceptor antagonist, significantly depressed depolarizations evoked by α,β‐methylene‐ATP (α,β‐MeATP; 100 μm), ATPγS (100 μm), CTP (1 μm), GTP (1 μm), ZTP (30 μm) and ATP (300 μm) in the presence of DPCPX (1 μm). Suramin reversed a small depolarization evoked by UMP (1 μm) into a small hyperpolarization. In contrast depolarizations evoked by UDP, UTP, UDPG (all at 100 μm) and TTP (300 μm) were unaltered or enhanced by suramin.
5
It is concluded that the rat SCG contains distinct nucleotide receptors including a P2‐purinoceptor (activated by α,β‐MeATP, ATP, GTP, ITP and ZTP) and a pyrimidinoceptor (activated by UTP, UDP, UDPG, UDPGA and TTP). The pyrimidinoceptor on rat SCG neurones had specific structure activity requirements with the di‐ and triphosphates of uridine being the most effective depolarizing agonists examined.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/j.1476-5381.1995.tb17239.x</identifier><identifier>PMID: 8591002</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adenosine 5′‐triphosphate ; Aminoglycosides ; Aminoimidazole Carboxamide - pharmacology ; Animals ; Anti-Bacterial Agents - pharmacology ; Biological and medical sciences ; Fundamental and applied biological sciences. Psychology ; Male ; Membrane Potentials - drug effects ; nucleotide ; P2‐purinoceptor ; Peripheral nervous system. Autonomic nervous system. Neuromuscular transmission. Ganglionic transmission. Electric organ ; Pyrimidine Nucleosides - metabolism ; Pyrimidine Nucleosides - pharmacology ; Pyrimidine Nucleotides - metabolism ; Pyrimidine Nucleotides - pharmacology ; Pyrimidines - metabolism ; Pyrimidines - pharmacology ; pyrimidinoceptor ; Rats ; Rats, Sprague-Dawley ; Receptors, Cell Surface - drug effects ; Receptors, Cell Surface - physiology ; Ribonucleotides - pharmacology ; Structure-Activity Relationship ; superior cervical ganglion (SCG) ; Superior Cervical Ganglion - drug effects ; Superior Cervical Ganglion - ultrastructure ; Suramin - pharmacology ; Uridine - analogs & derivatives ; Uridine - pharmacology ; uridine 5′‐triphosphate ; Uridine Triphosphate - pharmacology ; Vertebrates: nervous system and sense organs</subject><ispartof>British journal of pharmacology, 1995-11, Vol.116 (6), p.2764-2770</ispartof><rights>1995 British Pharmacological Society</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5389-135bcdb682a510c5955db1c587c55f1681614907e369b8dac258eb7485d5f50a3</citedby><cites>FETCH-LOGICAL-c5389-135bcdb682a510c5955db1c587c55f1681614907e369b8dac258eb7485d5f50a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1909137/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1909137/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2907549$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8591002$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Connolly, G.P.</creatorcontrib><creatorcontrib>Harrison, P. J.</creatorcontrib><title>Structure‐activity relationship of a pyrimidine receptor in the rat isolated superior cervical ganglion</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>1
The effects of pyrimidines and purines on the d.c. potential of the rat isolated superior cervical ganglion (SCG) have been examined by a grease‐gap technique to determine the structure‐activity requirements of the receptor activated by pyrimidines, i.e. a pyrimidinoceptor.
2
5‐Ammoimidazole‐4‐carboxamide‐1‐β‐D‐ribofuranosyl (ZTP), the pyrimidines, cytidine 5′‐triphosphate (CTP), uridine 5′‐triphosphate (UTP) and thymidine 5′‐triphosphate (TIT) and the purines, adenosine 5′‐triphosphate (ATP; in the presence of an A1‐purinoceptor antagonist 8‐cyclopentyl‐1,3‐dipropylxanthine (DPCPX) (1 μ)), adenosine 5′‐O‐(3‐thiotriphosphate) (ATPγS), guanosine 5′‐triphosphate (GTP), inosine 5′‐triphosphate (ITP) depolarized ganglia in a concentration‐dependent manner. The relative order of ZTP and purine 5′‐triphosphates in depolarizing ganglia was ZTP≥ATPγS > > ATP ≥ ITP=GTP, and for the pyrimidine 5′‐triphosphates UTP > TTP ≥ CTP. Depolarizations evoked by ATPγS were followed by concentration‐dependent hyperpolarizations at 100 and 1000 μm.
3
At concentrations of between 0.1 μm and 1 mm, uridine 5′‐diphosphate (UDP), uridine 5′‐diphospho‐glucose (UDPG) and uridine 5′‐diphosphoglucuronic acid (UDPGA) evoked significant and concentration‐dependent depolarizations, whereas uridine 5′‐monophosphate (UMP), uridine and uracil were inactive or produced small (< 45 μV) depolarizations. The relative order of potency of uridine analogues in depolarizing ganglia was UDP ≥ UTP > UDPG > UDPGA > > uracil≥ UMP=pseudour‐idine≥ uridine. At 3 and 10 mm, uridine produced concentration‐dependent hyperpolarizations. Nikkomycin Z, a nucleoside resembling UTP (viz. the triphosphate chain at the 5′‐position on the ribose moiety being replaced by a peptide), was inactive between 1 μm and 1 mm. Generally, a concentration of 10 mm was required before thymidine, 6‐azathymine, 6‐azauracil or 6‐azauridine depolarized ganglia.
4
Suramin (300 μm), a P2‐purinoceptor antagonist, significantly depressed depolarizations evoked by α,β‐methylene‐ATP (α,β‐MeATP; 100 μm), ATPγS (100 μm), CTP (1 μm), GTP (1 μm), ZTP (30 μm) and ATP (300 μm) in the presence of DPCPX (1 μm). Suramin reversed a small depolarization evoked by UMP (1 μm) into a small hyperpolarization. In contrast depolarizations evoked by UDP, UTP, UDPG (all at 100 μm) and TTP (300 μm) were unaltered or enhanced by suramin.
5
It is concluded that the rat SCG contains distinct nucleotide receptors including a P2‐purinoceptor (activated by α,β‐MeATP, ATP, GTP, ITP and ZTP) and a pyrimidinoceptor (activated by UTP, UDP, UDPG, UDPGA and TTP). The pyrimidinoceptor on rat SCG neurones had specific structure activity requirements with the di‐ and triphosphates of uridine being the most effective depolarizing agonists examined.</description><subject>Adenosine 5′‐triphosphate</subject><subject>Aminoglycosides</subject><subject>Aminoimidazole Carboxamide - pharmacology</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Male</subject><subject>Membrane Potentials - drug effects</subject><subject>nucleotide</subject><subject>P2‐purinoceptor</subject><subject>Peripheral nervous system. Autonomic nervous system. Neuromuscular transmission. Ganglionic transmission. Electric organ</subject><subject>Pyrimidine Nucleosides - metabolism</subject><subject>Pyrimidine Nucleosides - pharmacology</subject><subject>Pyrimidine Nucleotides - metabolism</subject><subject>Pyrimidine Nucleotides - pharmacology</subject><subject>Pyrimidines - metabolism</subject><subject>Pyrimidines - pharmacology</subject><subject>pyrimidinoceptor</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Cell Surface - drug effects</subject><subject>Receptors, Cell Surface - physiology</subject><subject>Ribonucleotides - pharmacology</subject><subject>Structure-Activity Relationship</subject><subject>superior cervical ganglion (SCG)</subject><subject>Superior Cervical Ganglion - drug effects</subject><subject>Superior Cervical Ganglion - ultrastructure</subject><subject>Suramin - pharmacology</subject><subject>Uridine - analogs & derivatives</subject><subject>Uridine - pharmacology</subject><subject>uridine 5′‐triphosphate</subject><subject>Uridine Triphosphate - pharmacology</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkdGK1DAUhoMo67j6CEIQ8a41p53TJF6IuqgrLCio1yFN05kMnbYm6bhzt4-wz-iTmNkpg16JuWnC95-fv-cn5BmwHNJ5uclhyasMSwE5SIl5rIEXpcyv75HFCd0nC8YYzwCEeEgehbBhLEGOZ-RMoATGigVxX6OfTJy8_XVzq010Oxf31NtORzf0Ye1GOrRU03Hv3dY1rrcJGjvGwVPX07hObx2pC0OasA0N02i9S9BYv3NGd3Sl-1WXvB6TB63ugn0yf8_J9w_vv11cZlefP366eHuVmRRaZlBibZq6EoVGYAYlYlODQcENYguVgAqWknFbVrIWjTYFClvzpcAGW2S6PCevj77jVG9tY2wfve7UmPJrv1eDdupv0ru1Wg07BZJJKHkyeDEb-OHHZENUWxeM7Trd22EKinNR8Gop_ykEztK6JSbhq6PQ-CEEb9tTGmDq0KjaqENt6lCbOjSq5kbVdRp--uf_nEbnChN_PnMd0r5br3vjwklWpF3hXdg3R9lP19n9fwRQ775c3l3L32PmwgM</recordid><startdate>199511</startdate><enddate>199511</enddate><creator>Connolly, G.P.</creator><creator>Harrison, P. J.</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199511</creationdate><title>Structure‐activity relationship of a pyrimidine receptor in the rat isolated superior cervical ganglion</title><author>Connolly, G.P. ; Harrison, P. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5389-135bcdb682a510c5955db1c587c55f1681614907e369b8dac258eb7485d5f50a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adenosine 5′‐triphosphate</topic><topic>Aminoglycosides</topic><topic>Aminoimidazole Carboxamide - pharmacology</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Male</topic><topic>Membrane Potentials - drug effects</topic><topic>nucleotide</topic><topic>P2‐purinoceptor</topic><topic>Peripheral nervous system. Autonomic nervous system. Neuromuscular transmission. Ganglionic transmission. Electric organ</topic><topic>Pyrimidine Nucleosides - metabolism</topic><topic>Pyrimidine Nucleosides - pharmacology</topic><topic>Pyrimidine Nucleotides - metabolism</topic><topic>Pyrimidine Nucleotides - pharmacology</topic><topic>Pyrimidines - metabolism</topic><topic>Pyrimidines - pharmacology</topic><topic>pyrimidinoceptor</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Cell Surface - drug effects</topic><topic>Receptors, Cell Surface - physiology</topic><topic>Ribonucleotides - pharmacology</topic><topic>Structure-Activity Relationship</topic><topic>superior cervical ganglion (SCG)</topic><topic>Superior Cervical Ganglion - drug effects</topic><topic>Superior Cervical Ganglion - ultrastructure</topic><topic>Suramin - pharmacology</topic><topic>Uridine - analogs & derivatives</topic><topic>Uridine - pharmacology</topic><topic>uridine 5′‐triphosphate</topic><topic>Uridine Triphosphate - pharmacology</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Connolly, G.P.</creatorcontrib><creatorcontrib>Harrison, P. J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Connolly, G.P.</au><au>Harrison, P. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structure‐activity relationship of a pyrimidine receptor in the rat isolated superior cervical ganglion</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>1995-11</date><risdate>1995</risdate><volume>116</volume><issue>6</issue><spage>2764</spage><epage>2770</epage><pages>2764-2770</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>1
The effects of pyrimidines and purines on the d.c. potential of the rat isolated superior cervical ganglion (SCG) have been examined by a grease‐gap technique to determine the structure‐activity requirements of the receptor activated by pyrimidines, i.e. a pyrimidinoceptor.
2
5‐Ammoimidazole‐4‐carboxamide‐1‐β‐D‐ribofuranosyl (ZTP), the pyrimidines, cytidine 5′‐triphosphate (CTP), uridine 5′‐triphosphate (UTP) and thymidine 5′‐triphosphate (TIT) and the purines, adenosine 5′‐triphosphate (ATP; in the presence of an A1‐purinoceptor antagonist 8‐cyclopentyl‐1,3‐dipropylxanthine (DPCPX) (1 μ)), adenosine 5′‐O‐(3‐thiotriphosphate) (ATPγS), guanosine 5′‐triphosphate (GTP), inosine 5′‐triphosphate (ITP) depolarized ganglia in a concentration‐dependent manner. The relative order of ZTP and purine 5′‐triphosphates in depolarizing ganglia was ZTP≥ATPγS > > ATP ≥ ITP=GTP, and for the pyrimidine 5′‐triphosphates UTP > TTP ≥ CTP. Depolarizations evoked by ATPγS were followed by concentration‐dependent hyperpolarizations at 100 and 1000 μm.
3
At concentrations of between 0.1 μm and 1 mm, uridine 5′‐diphosphate (UDP), uridine 5′‐diphospho‐glucose (UDPG) and uridine 5′‐diphosphoglucuronic acid (UDPGA) evoked significant and concentration‐dependent depolarizations, whereas uridine 5′‐monophosphate (UMP), uridine and uracil were inactive or produced small (< 45 μV) depolarizations. The relative order of potency of uridine analogues in depolarizing ganglia was UDP ≥ UTP > UDPG > UDPGA > > uracil≥ UMP=pseudour‐idine≥ uridine. At 3 and 10 mm, uridine produced concentration‐dependent hyperpolarizations. Nikkomycin Z, a nucleoside resembling UTP (viz. the triphosphate chain at the 5′‐position on the ribose moiety being replaced by a peptide), was inactive between 1 μm and 1 mm. Generally, a concentration of 10 mm was required before thymidine, 6‐azathymine, 6‐azauracil or 6‐azauridine depolarized ganglia.
4
Suramin (300 μm), a P2‐purinoceptor antagonist, significantly depressed depolarizations evoked by α,β‐methylene‐ATP (α,β‐MeATP; 100 μm), ATPγS (100 μm), CTP (1 μm), GTP (1 μm), ZTP (30 μm) and ATP (300 μm) in the presence of DPCPX (1 μm). Suramin reversed a small depolarization evoked by UMP (1 μm) into a small hyperpolarization. In contrast depolarizations evoked by UDP, UTP, UDPG (all at 100 μm) and TTP (300 μm) were unaltered or enhanced by suramin.
5
It is concluded that the rat SCG contains distinct nucleotide receptors including a P2‐purinoceptor (activated by α,β‐MeATP, ATP, GTP, ITP and ZTP) and a pyrimidinoceptor (activated by UTP, UDP, UDPG, UDPGA and TTP). The pyrimidinoceptor on rat SCG neurones had specific structure activity requirements with the di‐ and triphosphates of uridine being the most effective depolarizing agonists examined.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>8591002</pmid><doi>10.1111/j.1476-5381.1995.tb17239.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-1188 |
ispartof | British journal of pharmacology, 1995-11, Vol.116 (6), p.2764-2770 |
issn | 0007-1188 1476-5381 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1909137 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Adenosine 5′‐triphosphate Aminoglycosides Aminoimidazole Carboxamide - pharmacology Animals Anti-Bacterial Agents - pharmacology Biological and medical sciences Fundamental and applied biological sciences. Psychology Male Membrane Potentials - drug effects nucleotide P2‐purinoceptor Peripheral nervous system. Autonomic nervous system. Neuromuscular transmission. Ganglionic transmission. Electric organ Pyrimidine Nucleosides - metabolism Pyrimidine Nucleosides - pharmacology Pyrimidine Nucleotides - metabolism Pyrimidine Nucleotides - pharmacology Pyrimidines - metabolism Pyrimidines - pharmacology pyrimidinoceptor Rats Rats, Sprague-Dawley Receptors, Cell Surface - drug effects Receptors, Cell Surface - physiology Ribonucleotides - pharmacology Structure-Activity Relationship superior cervical ganglion (SCG) Superior Cervical Ganglion - drug effects Superior Cervical Ganglion - ultrastructure Suramin - pharmacology Uridine - analogs & derivatives Uridine - pharmacology uridine 5′‐triphosphate Uridine Triphosphate - pharmacology Vertebrates: nervous system and sense organs |
title | Structure‐activity relationship of a pyrimidine receptor in the rat isolated superior cervical ganglion |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T22%3A15%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structure%E2%80%90activity%20relationship%20of%20a%20pyrimidine%20receptor%20in%20the%20rat%20isolated%20superior%20cervical%20ganglion&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Connolly,%20G.P.&rft.date=1995-11&rft.volume=116&rft.issue=6&rft.spage=2764&rft.epage=2770&rft.pages=2764-2770&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1111/j.1476-5381.1995.tb17239.x&rft_dat=%3Cproquest_pubme%3E77827649%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17047795&rft_id=info:pmid/8591002&rfr_iscdi=true |